株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

医療用酵素:技術および世界市場

Medical Enzymes: Technologies and Global Markets

発行 BCC Research 商品コード 180725
出版日 ページ情報 英文 190 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.71円で換算しております。
Back to Top
医療用酵素:技術および世界市場 Medical Enzymes: Technologies and Global Markets
出版日: 2011年03月31日 ページ情報: 英文 190 Pages
概要

医療用酵素市場は成長しています。2010年は60億米ドルと見積もられており、今後CAGR3.9%で拡大しつづけ、2015年には72億米ドルに達すると見込まれています。治療用酵素が収益では最大セグメントで、2010年の53億米ドルからCAGR3.6%で2015年には63億米ドルを達成すると予測されています。分子研究に用いられる酵素は最速で拡大しています。2010年の5億4,600万米ドルから2015年には7億3,900万米ドル近くとなる見通しです。

当レポートでは、世界の医療用酵素市場について分析し、酵素の概要と分類、法規制動向、業界構造、参入企業のプロファイルなどをまとめ、概略下記の構成でお届けします。

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 概要

  • 定義
  • 酵素の構造
  • 活性化エネルギー
  • 特異性
  • 酵素基質の相互作用
  • 酵素作用の条件 他

第4章 酵素の分類

  • 医療用酵素分類
  • 治療法酵素
  • 診断用酵素
  • バイオメディカル研究用酵素

第5章 法規制の側面

第6章 業界構造

  • 治療用酵素の製造業者とサプライヤー
  • 診断用酵素の製造業者とサプライヤー
  • 分子診断で用いられる酵素製造業者とサプライヤー
  • 業界リーダーの市場シェア

第7章 新たな発展

  • 治療用酵素
  • 診断用酵素
  • 分子診断で用いられる酵素

第8章 市場分析

第9章 応用別市場

  • 治療用酵素の応用
  • 診断用酵素
  • 分子研究用酵素

第10章 特許分析

第11章 現状

  • 酵素市場への影響因子

第12章 企業プロファイル

第13章 付録

図表

目次
Product Code: BIO082A

Abstract

REPORT HIGHLIGHTS

  • The market for enzymes in medicine is growing. The global market for medical enzymes is estimated at $6 billion in 2010. The market is growing at a compound annual growth rate (CAGR) of 3.9%, to reach $7.2 billion in 2015.
  • Therapeutic enzymes are the biggest segment in terms of revenues generated. This sector was valued at $5.3 billion in 2010 and is expected to increase at a 3.6% compound annual growth rate (CAGR) to reach $6.3 billion in 2015.
  • Enzymes used in molecular research will experience the fastest compound annual growth rate (CAGR), 6.2%, over the study period. This sector was worth $546 million in 2010 and should reach nearly $739 million by 2015.

SSUMMARY FIGURE
WORLDWIDE REVENUE OF MEDICAL ENZYMES MARKET, 2010 AND 2015
($ MILLIONS)

image1

Source: BCC Research

REPORT SCOPE

INTRODUCTION

STUDY GOAL OBJECTIVES

BCC' s goal in conducting this study is to provide an overview of the current and future characteristics of the global market for medical enzymes. The key objective is to present a comprehensive analysis of the current market and its future direction as an important tool for increasing the efficiency and specificity of the products in which medical enzymes are used.

This report explores present and future strategies within the medical enzymes market, which includes the therapeutic, diagnostics, and molecular research sector. The improvisation of the market, the setbacks, and the needs of the market are discussed in this report. The nomenclature, history, and the classification of different types of enzymes are also discussed.

A detailed analysis of the structure of the medical enzymes industry has been conducted. Revenues are broken down by global region. Sales figures are estimated for the 5-year period from 2010 through 2015.

Applications or the uses of medical enzymes are also discussed separately in the report, with emphasis on the usage in various disease sectors. The report also covers the usage of enzymes for diagnostic purposes and in molecular research like sequencing, mapping, and so on. The report also covers significant patents and their number in each category.

REASONS FOR DOING THIS STUDY

CONTRIBUTIONS of THE STUDY AND ITS INTENDED AUDIENCE

This study contributes to the areas of market growth in therapeutic, diagnostic, and research enzyme manufacturers and users. Pharmaceutical, chemical, biochemical, and biotechnical companies, industries, and research institutes will find this study to be of interest.

SCOPE of THE STUDY

The scope of this study encompasses medical or medicinal enzymes, bio-technical, pharmaceutical, and biotechnology markets. BCC analyzes each market and its applications, regulatory environment, technology involved, market projections, and market share. Technological issues include the latest trends and developments.

METHODOLOGY

BCC conducted a comprehensive literature search, which included technical newsletters and journals, and many other sources. Data were collected through interviews and correspondence with various chemical, biotechnical, food and beverages, and technical experts. Projections were based on estimates such as the current number of end users, potential end users, mergers and acquisitions, and market trends.

INFORMATION SOURCES

Many companies within the industry were surveyed to obtain data for this study. Included were manufacturers and end users of enzymes in therapeutic, diagnostic, and molecular research industries. Data were gathered from various industry sources. BCC spoke with officials within the industry, consulted newsletters, company literature, product literature, and a host of technical articles, journals, indexes, and abstracts. Exhaustive investigations of databases by key terminology were completed. In addition, data were compiled from current financial, trade, and government sources.

Table of Contents

Chapter- 1: INTRODUCTION - Complimentary

  • STUDY GOAL OBJECTIVES
  • REASONS FOR DOING THIS STUDY
  • CONTRIBUTIONS OF THE STUDY AND ITS INTENDED AUDIENCE
  • SCOPE OF THE STUDY
  • METHODOLOGY
  • INFORMATION SOURCES
  • ANALYSTS' CREDENTIALS
  • RELATED BCC RESEARCH REPORTS
  • BCC ONLINE SERVICES
  • DISCLAIMER

Chapter- 2: EXECUTIVE SUMMARY

  • Table 0 : WORLDWIDE REVENUE OF MEDICAL ENZYMES MARKET, THROUGH 2015
  • Figure 0 : WORLDWIDE REVENUE OF MEDICAL ENZYMES MARKET, 2010 AND 2015

Chapter- 3: OVERVIEW

  • DEFINITIONS
  • STRUCTURE OF ENZYMES
  • ACTIVATION ENERGY
  • SPECIFICITY
  • ENZYME SUBSTRATE INTERACTION
  • CONDITIONS OF ENZYME ACTION
  • NOMENCLATURE OF ENZYMES
  • HISTORY OF ENZYMES
  • CLASSIFICATION
  • REAL-LIFE APPLICATIONS OF ENZYMES
  • THE HUMAN BODY NEEDS ENZYMES
  • ENZYMES IN MEDICINE
    • Table 1 : EXAMPLES OF ENZYMES, THEIR SOURCES AND REACTIONS THEY CATALYZE

Chapter- 4: CLASSIFICATION OF ENZYMES

  • CLASSIFICATION OF MEDICAL ENZYMES
  • THERAPEUTIC ENZYMES
  • DIAGNOSTIC ENZYMES
  • ENZYMES FOR BIOMEDICAL RESEARCH

Chapter- 5: REGULATORY ASPECTS

  • Table 18 : NEW APPROVALS FOR THERAPEUTIC ENZYMES
  • Table 19 : NEW DRUG APPLICATIONS FOR THERAPEUTIC ENZYMES

Chapter- 6: INDUSTRY STRUCTURE

  • MANUFACTURERS/ SUPPLIERS FOR THERAPEUTIC ENZYMES
  • MANUFACTURERS/ SUPPLIERS FOR DIAGNOSTIC ENZYMES
  • MANUFACTURERS/ SUPPLIERS FOR ENZYMES USED IN MOLECULAR RESEARCH
  • MARKET SHARES OF INDUSTRY LEADERS

Chapter- 7: NEW DEVELOPMENTS

  • THERAPEUTIC ENZYMES
  • DIAGNOSTIC ENZYMES
  • MOLECULAR RESEARCH ENZYMES

Chapter- 8: MARKET ANALYSIS

  • THERAPEUTIC ENZYMES
  • DIAGNOSTIC ENZYMES
  • ENZYMES USED FOR MOLECULAR RESEARCH
    • Table 56 : GLOBAL MARKET FOR MOLECULAR RESEARCH ENZYMES, BY TYPE, THROUGH 2015
    • Figure 25 : GLOBAL MARKET FOR MOLECULAR RESEARCH ENZYMES, BY TYPE, THROUGH 2015

Chapter- 9: MARKET BY APPLICATIONS

  • APPLICATIONS FOR THERAPEUTIC ENZYMES
  • DIAGNOSTIC ENZYMES
  • MOLECULAR RESEARCH ENZYMES
    • Table 74 : GLOBAL SALES OF MOLECULAR RESEARCH ENZYMES, BY APPLICATIONS, THROUGH 2015
    • Figure 43 : GLOBAL SALES OF MOLECULAR RESEARCH ENZYMES, BY APPLICATIONS, THROUGH 2015

Chapter- 10: PATENT ANALYSIS

  • PATENTS BY YEAR
  • PATENTS BY CATEGORY
  • PATENTS BY TYPE
  • PATENTS BY COMPANY
  • PATENTS BY COUNTRY
  • PATENTS BY ASSIGNEE
    • Table 84 : PATENTS BY TYPE OF ASSIGNEE FOR MEDICINAL ENZYMES, 2006 - 2010
    • Figure 54 : PATENTS BY ASSGINEE TYPE FOR MEDICINAL ENZYMES, 2006 - 2010

Chapter- 11: CURRENT SITUATION

  • FACTORS AFFECTING ENZYMES MARKET

Chapter- 12: COMPANY PROFILES

  • AGILENT TECHNOLOGIES
  • AMANO ENZYME INC.
  • AMPHASTAR PHARMACEUTICALS INC.
  • ASAHI KASEI PHARMA
  • AUXILIUM PHARMACEUTICALS INC.
  • AXCAN PHARMA INC.
  • BBI ENZYMES
  • BIOCATALYSTS LTD
  • BIOMARIN PHARMACEUTICALS INC.
  • BOEHRINGER INGELHEIM GMBH
  • BIOSPECIFIC TECHNOLOGIES CORP.
  • CSL BEHRING
  • DIGESTIVE CARE INC.
  • EKR THERAPEUTICS
  • ENZON PHARMACEUTICALS INC.
  • EURAND N.V.
  • EUSA PHARM
  • GE HEALTHCARE LIFE SCIENCES
  • GENENTECH INC.
  • GENZYME CORP.
  • GENZYME DIAGNOSTICS
  • HALOZYME THERAPEUTICS INC
  • ISTA PHARMACEUTICALS
  • LIFE TECHNOLOGIES CORP.
  • PROMEGA CORP.
  • PROTALIX BIOTHERAPEUTICS INC.
  • ROCHE APPLIED SCIENCES
  • SANOFI-AVENTIS U.S.
  • SHIRE plc
  • SIGMA ALDRICH CORP.
  • SOLVAY PHARMACEUTICAL INC.
  • THERMO FISHER SCIENTIFIC, INC.

Chapter- 13: APPENDIX

ABBREVIATIONS

List of Tables

  • Table 1 : EXAMPLES OF ENZYMES, THEIR SOURCES AND REACTIONS THEY CATALYZE
  • Table 2 : THERAPEUTIC ENZYMES
  • Table 3 : DIAGNOSTIC ENZYMES
  • Table 4 : BIOMEDICAL ENZYMES
  • Table 5 : PANCREATIC ENZYME PRODUCTS
  • Table 6 : LYSOSOMAL ENZYME PRODUCTS
  • Table 7 : THROMBOLYTIC ENZYME PRODUCTS
  • Table 8 : OTHER ENZYME PRODUCTS
  • Table 9 : EXAMPLES OF OXIDOREDUCTASE
  • Table 10 : EXAMPLES OF HYDROLASES
  • Table 11 : EXAMPLES OF TRANSFERASES
  • Table 12 : EXAMPLES OF LYSASES
  • Table 13 : EXAMPLES OF LYSING ENZYMES
  • Table 14 : EXAMPLES OF CLEAVING ENZYMES
  • Table 15 : EXAMPLES OF SYNTHESIZING ENZYMES
  • Table 16 : EXAMPLES OF JOINING ENZYMES
  • Table 17 : EXAMPLES OF ALKALINE PHOSPHATASE ENZYMES
  • Table 18 : NEW APPROVALS FOR THERAPEUTIC ENZYMES
  • Table 19 : NEW DRUG APPLICATIONS FOR THERAPEUTIC ENZYMES
  • Table 20 : LEADING MANUFACTURERS/SUPPLIERS OF DIGESTIVE ENZYME PRODUCTS/PANCREATIC ENZYME PRODUCTS
  • Table 21 : LEADING MANUFACTURERS/SUPPLIERS OF LYSOSOMAL ENZYME PRODUCTS
  • Table 22 : LEADING MANUFACTURERS/SUPPLIERS OF THROMBOLYTIC ENZYME PRODUCTS
  • Table 23 : LEADING MANUFACTURERS/SUPPLIERS OF OTHER ENZYME PRODUCTS
  • Table 24 : LEADING MANUFACTURERS/SUPPLIERS OF OXIDOREDUCTASES
  • Table 25 : LEADING MANUFACTURERS/SUPPLIERS OF HYDROLASES
  • Table 26 : LEADING MANUFACTURERS/SUPPLIERS OF TRANSFERASES
  • Table 27 : LEADING MANUFACTURERS/SUPPLIERS OF LYASES, LIGASES, AND ISOMERASES
  • Table 28 : LEADING MANUFACTURERS/SUPPLIERS OF LYSOSOMAL ENZYME PRODUCTS
  • Table 29 : LEADING MANUFACTURERS/SUPPLIERS OF SYNTHESIZING ENZYMES
  • Table 30 : LEADING MANUFACTURERS/SUPPLIERS OF OTHER ENZYMES USED IN RESEARCH
  • Table 31 : WORLDWIDE MARKET SHARES OF DIGESTIVE ENZYME MANUFACTURERS, 2009
  • Table 32 : WORLDWIDE MARKET SHARES OF LYSOSOMAL ENZYME MANUFACTURERS, 2009
  • Table 33 : WORLDWIDE MARKET SHARES OF THROMBOLYTIC ENZYME MANUFACTURERS, 2009
  • Table 34 : WORLDWIDE MARKET SHARES OF THROMBOLYTIC ENZYME MANUFACTURERS, 2009
  • Table 35 : WORLDWIDE MARKET SHARES OF OXIDOREDUCTASE MANUFACTURERS, 2009
  • Table 36 : WORLDWIDE MARKET SHARES OF HYDROLASE MANUFACTURERS, 2009
  • Table 37 : WORLDWIDE MARKET SHARES OF TRANSFERASE MANUFACTURERS, 2009
  • Table 38 : WORLDWIDE MARKET SHARES OF OTHER DIAGNOSTIC ENZYME MANUFACTURERS, 2009
  • Table 39 : WORLDWIDE MARKET SHARES OF CLEAVING ENZYME MANUFACTURERS, 2009
  • Table 40 : WORLDWIDE MARKET SHARES OF SYNTHESIZING ENZYME MANUFACTURERS, 2009
  • Table 41 : WORLDWIDE MARKET SHARES OF MANUFACTURERS OF OTHER ENZYMES USED IN RESEARCH, 2009
  • Table 42 : NEW DEVELOPMENTS IN THERAPEUTIC ENZYMES
  • Table 43 : GLOBAL MARKET FOR MEDICAL ENZYMES, THROUGH 2015
  • Table 44 : GLOBAL MARKET FOR THERAPEUTIC ENZYMES MARKET BY TYPE, THROUGH 2015
  • Table 45 : WORLDWIDE MARKET FOR DIGESTIVE ENZYMES BY REGION, THROUGH 2015
  • Table 46 : WORLDWIDE MARKET FOR LYSOSOMAL ENZYME PRODUCTS BY REGION, THROUGH 2015
  • Table 47 : WORLDWIDE MARKET FOR THROMBOLYTIC ENZYME PRODUCTS, BY REGION, THROUGH 2015
  • Table 48 : WORLDWIDE MARKET FOR OTHER ENZYME PRODUCTS, BY REGION, THROUGH 2015
  • Table 49 : WORLDWIDE THERAPEUTIC ENZYME MARKET SHARES, BY REGION, 2009
  • Table 50 : GLOBAL MARKET FOR DIAGNOSTICS ENZYMES BY TYPE, THROUGH 2015
  • Table 51 : WORLDWIDE MARKET FOR OXIDOREDUCTASES BY REGION, THROUGH 2015
  • Table 52 : WORLDWIDE MARKET FOR HYDROLASES, BY REGION, THROUGH 2015
  • Table 53 : WORLDWIDE MARKET FOR TRANSFERASES, BY REGION, THROUGH 2015
  • Table 54 : WORLDWIDE MARKET FOR OTHER ENZYMES (LYASES, LYDASES, AND ISOMERASES), BY REGION, THROUGH 2015
  • Table 55 : WORLDWIDE DIAGNOSTICS ENZYME MARKET SHARES, BY REGION, 2009
  • Table 56 : GLOBAL MARKET FOR MOLECULAR RESEARCH ENZYMES, BY TYPE, THROUGH 2015
  • Table 57 : WORLDWIDE MARKET FOR CLEAVING ENZYMES, BY REGION, THROUGH 2015
  • Table 58 : WORLDWIDE MARKET FOR SYNTHESIZING ENZYMES, BY REGION, THROUGH 2015
  • Table 59 : WORLDWIDE MARKET FOR OTHER ENZYMES USED IN RESEARCH, BY REGION, THROUGH 2015
  • Table 60 : WORLDWIDE ENZYMES USED IN MOLECULAR RESEARCH, MARKET SHARES, BY REGION, 2009
  • Table 61 : GLOBAL SALES OF THERAPEUTIC ENZYMES, BY APPLICATIONS, THROUGH 2015
  • Table 62 : WORLDWIDE MARKET SHARE OF THERAPEUTIC ENZYME MANUFACTURERS IN CARDIOVASCULAR DISEASE MARKET IN 2009
  • Table 63 : WORLDWIDE MARKET SHARE OF THERAPEUTIC ENZYME MANUFACTURERS IN THE CANCER MARKET, 2009
  • Table 64 : WORLDWIDE MARKET SHARE OF THERAPEUTIC ENZYME MANUFACTURERS IN THE PULMONARY EMBOLISM MARKET, 2009
  • Table 65 : WORLDWIDE MARKET SHARE OF THERAPEUTIC ENZYME MANUFACTURERS IN THE POMPE DISEASE MARKET, 2009
  • Table 66 : WORLDWIDE MARKET SHARE OF THERAPEUTIC ENZYME MANUFACTURERS IN THE FABRY DISEASE MARKET, 2009
  • Table 67 : WORLDWIDE MARKET SHARE OF THERAPEUTIC ENZYME MANUFACTURERS IN THE GAUCHER' S DISEASE MARKET, 2009
  • Table 68 : WORLDWIDE MARKET SHARE OF THERAPEUTIC ENZYME MANUFACTURERS IN THE MUCOPOLYSACCHARIDOSES MARKET, 2009
  • Table 69 : WORLDWIDE MARKET SHARE OF THERAPEUTIC ENZYME MANUFACTURERS IN THE CYSTIC FIBROSIS AND ASSOCIATED DISEASE MARKET, 2009
  • Table 70 : WORLDWIDE MARKET SHARE OF THERAPEUTIC ENZYME MANUFACTURERS IN THE OTHER DISEASES MARKET, 2009
  • Table 71 : WORLDWIDE MARKET SHARE FOR THERAPEUTIC ENZYMES BY APPLICATIONS IN 2009
  • Table 72 : GLOBAL SALES OF DIAGNOSTIC ENZYMES, BY APPLICATIONS, THROUGH 2015
  • Table 73 : WORLDWIDE MARKET SHARE OF DIAGNOSTICS ENZYMES, BY APPLICATION, 2009
  • Table 74 : GLOBAL SALES OF MOLECULAR RESEARCH ENZYMES, BY APPLICATIONS, THROUGH 2015
  • Table 75 : WORLDWIDE MARKET SHARES FOR MOLECULAR RESEARCH ENZYMES, BY APPLICATION, 2009
  • Table 76 : NUMBER OF PATENTS, BY YEAR, 2006 - 2010
  • Table 77 : PATENTS BY CATEGORY FOR MEDICINAL ENZYMES, 2006 - 2010
  • Table 78 : THERAPEUTIC ENZYME PATENTS BY TYPE, 2006 - 2010
  • Table 79 : DIAGNOSTICS ENZYMES PATENTS BY TYPE, 2006 - 2010
  • Table 80 : RESEARCH ENZYMES PATENTS BY TYPE, 2006 - 2010
  • Table 81 : NUMBER OF U.S. PATENTS BY COMPANY FOR MEDICINAL ENZYMES, 2006 - 2010
  • Table 82 : NUMBER OF U.S. PATENTS BY COUNTRY FOR MEDICINAL ENZYMES, 2006 - 2010
  • Table 83 : PATENT SHARES BY COUNTRY FOR MEDICINAL ENZYMES, 2006 - 2010
  • Table 84 : PATENTS BY TYPE OF ASSIGNEE FOR MEDICINAL ENZYMES, 2006 - 2010

List of Figures

  • Figure 1 : WORLDWIDE MARKET SHARES OF DIGESTIVE ENZYME MANUFACTURERS, 2009
  • Figure 2 : WORLDWIDE MARKET SHARES OF LYSOSOMAL ENZYME MANUFACTURERS, 2009
  • Figure 3 : WORLDWIDE MARKET SHARES OF THROMBOLYTIC ENZYME MANUFACTURERS, 2009
  • Figure 4 : WORLDWIDE MARKET SHARES OF OTHER ENZYMES MANUFACTURERS, 2009
  • Figure 5 : WORLDWIDE MARKET SHARES OF OXIDOREDUCTASE MANUFACTURERS, 2009
  • Figure 6 : WORLDWIDE MARKET SHARES OF HYDROLASE MANUFACTURERS, 2009
  • Figure 7 : WORLDWIDE MARKET SHARES OF TRANSFERASE MANUFACTURERS, 2009
  • Figure 8 : WORLDWIDE MARKET SHARES OF OTHER DIAGNOSTIC ENZYME MANUFACTURERS, 2009
  • Figure 9 : WORLDWIDE MARKET SHARES OF CLEAVING ENZYME MANUFACTURERS, 2009
  • Figure 10 : WORLDWIDE MARKET SHARES OF SYNTHESIZING ENZYME MANUFACTURERS, 2009
  • Figure 11 : WORLDWIDE MARKET SHARES OF MANUFACTURERS OF OTHER ENZYMES USED IN RESEARCH, 2009
  • Figure 12 : GLOBAL MARKET FOR MEDICAL ENZYMES, THROUGH 2015
  • Figure 13 : GLOBAL MARKET FOR THERAPEUTIC ENZYMES MARKET BY TYPE, THROUGH 2015
  • Figure 14 : WORLDWIDE MARKET FOR DIGESTIVE ENZYMES BY REGION, THROUGH 2015
  • Figure 15 : WORLDWIDE MARKET FOR LYSOSOMAL ENZYME PRODUCTS BY REGION, THROUGH 2015
  • Figure 16 : WORLDWIDE MARKET FOR THROMBOLYTIC ENZYME PRODUCTS, BY REGION, THROUGH 2015
  • Figure 17 : WORLDWIDE MARKET FOR OTHER ENZYME PRODUCTS BY REGION, THROUGH 2015
  • Figure 18 : WORLDWIDE THERAPEUTIC ENZYME MARKET SHARES, BY REGION, 2009
  • Figure 19 : GLOBAL MARKET FOR DIAGNOSTICS ENZYMES BY TYPE, 2008-2015
  • Figure 20 : WORLDWIDE MARKET FOR OXIDOREDUCTASES, BY REGION, 2008-2015
  • Figure 21 : WORLDWIDE MARKET FOR HYDROLASES, BY REGION, 2008-2015
  • Figure 22 : WORLDWIDE MARKET FOR TRANSFERASES, BY REGION, 2008-2015
  • Figure 23 : WORLDWIDE MARKET FOR OTHER ENZYMES (LYASES, LYDASES, AND ISOMERASES), BY REGION, 2008-2015
  • Figure 24 : WORLDWIDE DIAGNOSTICS ENZYME MARKET SHARES, BY REGION, 2009
  • Figure 25 : GLOBAL MARKET FOR MOLECULAR RESEARCH ENZYMES, BY TYPE, THROUGH 2015
  • Figure 26 : WORLDWIDE MARKET FOR CLEAVING ENZYMES, BY REGION, THROUGH 2015
  • Figure 27 : WORLDWIDE MARKET FOR SYNTHESIZING ENZYMES, BY REGION, 2008-2015
  • Figure 28 : WORLDWIDE MARKET FOR OTHER ENZYMES USED IN RESEARCH, BY REGION, 2008-2015
  • Figure 29 : WORLDWIDE ENZYMES USED IN MOLECULAR RESEARCH, MARKET SHARES, BY REGION, 2009
  • Figure 30 : GLOBAL SALES OF THERAPEUTIC ENZYMES, BY APPLICATIONS, THROUGH 2015
  • Figure 31 : WORLDWIDE MARKET SHARE OF THERAPEUTIC ENZYME MANUFACTURERS IN CARDIOVASCULAR DISEASE MARKET, 2009
  • Figure 32 : WORLDWIDE MARKET SHARE OF THERAPEUTIC ENZYME MANUFACTURERS IN THE CANCER MARKET, 2009
  • Figure 33 : WORLDWIDE MARKET SHARE OF THERAPEUTIC ENZYME MANUFACTURERS IN THE PULMONARY EMBOLISM MARKET, 2009
  • Figure 34 : WORLDWIDE MARKET SHARE OF THERAPEUTIC ENZYME MANUFACTURERS IN POMPE DISEASE MARKET, 2009
  • Figure 35 : WORLDWIDE MARKET SHARE OF THERAPEUTIC ENZYME MANUFACTURERS IN THE FABRY DISEASE MARKET, 2009
  • Figure 36 : WORLDWIDE MARKET SHARE OF THERAPEUTIC ENZYME MANUFACTURERS IN THE GAUCHER' S DISEASE MARKET, 2009
  • Figure 37 : WORLDWIDE MARKET SHARE OF THERAPEUTIC ENZYME MANUFACTURERS IN THE MUCOPOLYSACCHARIDOSES MARKET, 2009
  • Figure 38 : WORLDWIDE MARKET SHARE OF THERAPEUTIC ENZYME MANUFACTURERS IN THE CYSTIC FIBROSIS AND ASSOCIATED DISEASE MARKET, 2009
  • Figure 39 : WORLDWIDE MARKET SHARE OF THERAPEUTIC ENZYME MANUFACTURERS IN THE OTHER DISEASES MARKET, 2009
  • Figure 40 : WORLDWIDE MARKET SHARE FOR THERAPEUTIC ENZYMES BY APPLICATIONS, 2009
  • Figure 41 : GLOBAL SALES OF DIAGNOSTIC ENZYMES, BY APPLICATIONS, THROUGH 2015
  • Figure 42 : WORLDWIDE MARKET SHARE OF DIAGNOSTICS ENZYMES, BY APPLICATION, 2009
  • Figure 43 : GLOBAL SALES OF MOLECULAR RESEARCH ENZYMES, BY APPLICATIONS, THROUGH 2015
  • Figure 44 : WORLDWIDE MARKET SHARES FOR MOLECULAR RESEARCH ENZYMES, BY APPLICATION, 2009
  • Figure 45 : NUMBER OF PATENTS BY YEAR, 2006 - 2010
  • Figure 46 : NUMBER OF PATENTS BY YEAR, 2006 - 2010
  • Figure 47 : PATENTS BY CATEGORY FOR MEDICINAL ENZYMES AGENTS, 2006 - 2010
  • Figure 48 : THERAPEUTIC ENZYMES PATENTS BY TYPE, 2006 - 2010
  • Figure 49 : DIAGNOSTICS ENZYMES PATENTS BY TYPE, 2006 - 2010
  • Figure 50 : RESEARCH ENZYMES PATENTS BY TYPE, 2006 - 2010
  • Figure 51 : NUMBER OF U.S. PATENTS BY COMPANY FOR MEDICINAL ENZYMES, 2006 - 2010
  • Figure 52 : NUMBER OF U.S. PATENTS BY COUNTRY FOR MEDICINAL ENZYMES, 2006 - 2010
  • Figure 53 : PATENT SHARES BY COUNTRY FOR MEDICINAL ENZYMES, 2006 - 2010
  • Figure 54 : PATENTS BY ASSGINEE TYPE FOR MEDICINAL ENZYMES, 2006 - 2010
Back to Top